Suppr超能文献

结核性葡萄膜炎的视觉及治疗效果:来自巴基斯坦一家转诊医院的前瞻性病例系列研究

Visual and treatment outcomes of tubercular uveitis: a prospective case series from a referral hospital in Pakistan.

作者信息

Ghauri Muhammad Ishaq, Iqbal Nousheen, Riaz Syeda Urooj, Irfan Muhammad, Kumar Ajeet, Mukarram Muhamad Shariq

机构信息

Department of Medicine, Jinnah Medical College Hospital, Karachi, Pakistan.

Section of Pulmonary and Critical Care Medicine, Department of Medicine, Aga Khan University, Stadium Road, Karachi, Pakistan.

出版信息

BMC Res Notes. 2019 Jul 15;12(1):404. doi: 10.1186/s13104-019-4432-8.

Abstract

OBJECTIVE

Pakistan is the fifth highest TB burden country. Tuberculous uveitis (TbU) is a form of extrapulmonary TB, that is not uncommon in high burden country but very limited data is available on its outcome. The aim of the study is to assess the outcome of TbU with anti-tuberculous treatment (ATT).

RESULTS

A prospective study was conducted at Jinnah Medical College Hospital (JMCH) Karachi, Pakistan from July to December 2017. Patients with suspected TbU were started on standard ATT chemotherapy for 12 months. Their response was assessed via slit lamp examination and visual acuity at 1, 3, 6 and 12 months of treatment. Forty patients with probable TbU were treated with ATT, mean age was 36 ± 3 years and 24 (60%) were females. Around 26 (65%) had Monteux test of 15 mm or more. History of TB contact was positive in 24 (60%) and 12 (30%) had previous history of TB. All patients complained for blurring of vision and floaters. Posterior uveitis seen in 36 (90%) of patients. Complete response achieved in 32 (80%) after ATT while 6 (14%) had changed in inflammation and 2 (6%) had no benefit.

摘要

目的

巴基斯坦是结核病负担第五高的国家。结核性葡萄膜炎(TbU)是肺外结核的一种形式,在高负担国家并不罕见,但关于其预后的数据非常有限。本研究的目的是评估抗结核治疗(ATT)对结核性葡萄膜炎的疗效。

结果

2017年7月至12月在巴基斯坦卡拉奇的真纳医学院医院(JMCH)进行了一项前瞻性研究。疑似结核性葡萄膜炎的患者开始接受为期12个月的标准抗结核化疗。在治疗的1、3、6和12个月时,通过裂隙灯检查和视力评估他们的反应。40例可能患有结核性葡萄膜炎的患者接受了抗结核治疗,平均年龄为36±3岁,24例(60%)为女性。约26例(65%)的结核菌素试验结果为15mm或更大。24例(60%)有结核接触史,12例(30%)有既往结核病史。所有患者均主诉视力模糊和有飞蚊症。36例(90%)患者出现后葡萄膜炎。抗结核治疗后32例(80%)完全缓解,6例(14%)炎症有变化,2例(6%)无改善。

相似文献

2
Diagnosis and treatment of tuberculous uveitis in a low endemic setting.
Int J Infect Dis. 2013 Nov;17(11):e993-9. doi: 10.1016/j.ijid.2013.03.019. Epub 2013 May 22.
3
[Treatment of presumed tuberculous uveitis affecting the posterior segment: diagnostic confirmation and long term outcomes].
Arch Soc Esp Oftalmol. 2013 Sep;88(9):339-44. doi: 10.1016/j.oftal.2012.11.011. Epub 2013 Apr 3.
6
Early treatment of tuberculous uveitis improves visual outcome: a 10-year cohort study.
Infection. 2018 Aug;46(4):549-554. doi: 10.1007/s15010-018-1161-1. Epub 2018 Jun 4.
7
Anti-tubercular therapy in the treatment of tubercular uveitis: A systematic review and meta-analysis.
Surv Ophthalmol. 2023 Mar-Apr;68(2):241-256. doi: 10.1016/j.survophthal.2022.10.001. Epub 2022 Oct 19.
9
Effect of Antituberculous Therapy on Uveitis Associated With Latent Tuberculosis.
Am J Ophthalmol. 2018 Jun;190:164-170. doi: 10.1016/j.ajo.2018.03.032. Epub 2018 Mar 29.
10
Global prevalence and clinical outcomes of tubercular uveitis: a systematic review and meta-analysis.
Surv Ophthalmol. 2022 May-Jun;67(3):770-792. doi: 10.1016/j.survophthal.2021.10.001. Epub 2021 Oct 7.

引用本文的文献

1
A systemic review of the utility of antituberculosis therapy for presumed tuberculous uveitis.
BMC Infect Dis. 2025 Jan 24;25(1):112. doi: 10.1186/s12879-024-10288-1.
2
BTS clinical statement for the diagnosis and management of ocular tuberculosis.
BMJ Open Respir Res. 2022 Mar;9(1). doi: 10.1136/bmjresp-2022-001225.

本文引用的文献

1
Ocular tuberculosis: current perspectives.
Clin Ophthalmol. 2015 Nov 26;9:2223-7. doi: 10.2147/OPTH.S65254. eCollection 2015.
2
Pattern of uveitis at a referral center in Iraq.
Middle East Afr J Ophthalmol. 2014 Oct-Dec;21(4):291-5. doi: 10.4103/0974-9233.142263.
3
Diagnosis and treatment of tuberculous uveitis in a low endemic setting.
Int J Infect Dis. 2013 Nov;17(11):e993-9. doi: 10.1016/j.ijid.2013.03.019. Epub 2013 May 22.
4
Uveitis is not just an ophthalmologists' concern.
J Pak Med Assoc. 2012 Feb;62(2):92-7.
5
QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation.
Am J Ophthalmol. 2011 Sep;152(3):433-440.e1. doi: 10.1016/j.ajo.2011.02.006. Epub 2011 Jun 8.
6
Presumed tuberculous uveitis: diagnosis, management, and outcome.
Eye (Lond). 2011 Apr;25(4):475-80. doi: 10.1038/eye.2010.235. Epub 2011 Feb 4.
7
Ocular tuberculosis: a clinicopathologic and molecular study.
Ophthalmology. 2011 Apr;118(4):772-7. doi: 10.1016/j.ophtha.2010.08.011. Epub 2010 Nov 4.
8
Tuberculous uveitis.
Middle East Afr J Ophthalmol. 2009 Oct;16(4):188-201. doi: 10.4103/0974-9233.58421.
9
Ocular tuberculosis: diagnostic and treatment challenges.
Int J Infect Dis. 2009 Jul;13(4):432-5. doi: 10.1016/j.ijid.2008.09.018. Epub 2009 Apr 22.
10
Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis.
Int Ophthalmol. 2008 Dec;28(6):413-23. doi: 10.1007/s10792-007-9170-6. Epub 2007 Nov 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验